A refined use of mutations to guide immunotherapy decisions
- PMID: 36536222
- DOI: 10.1038/d41586-022-04448-z
A refined use of mutations to guide immunotherapy decisions
Keywords: Cancer; Medical research.
Comment on
-
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.Cancer Cell. 2022 Oct 10;40(10):1161-1172.e5. doi: 10.1016/j.ccell.2022.08.022. Epub 2022 Sep 29. Cancer Cell. 2022. PMID: 36179682 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical